Fresenius Medical Care launches new dialysis machine in China

It is crucial to make sure that more cost-effective solutions are available for these patients in need of life-sustaining dialysis therapy.

Fresenius Medical Care, the world’s leading provider of dialysis products and services, has announced the launch of its 4008A^TM dialysis machine in China.

The product is exclusively designed to incorporate Fresenius Medical Care’s high-quality standards while reducing costs for health care systems, meeting the needs in emerging markets. With the launch of the 4008A^TM, Fresenius Medical Care is aiming to bring quality life-sustaining dialysis treatment to more patients in China who are suffering from end-stage renal disease (ESRD).

The 4008A^TM dialysis machine is a major innovation and a joined outcome of the beneficial collaboration between the Fresenius Medical Care China Design Center in Shanghai and the company’s Research and Development teams in Germany.

ESRD is the stage in kidney disease when a person's kidneys permanently stop working properly. To stay alive, the patient will need to undergo long-term dialysis or receive a kidney transplant. Currently more than 600,000 patients in China had access to dialysis, but the estimated ESRD prevalence is much higher.

-----------------------------------------------------------------------
Editor's Note: For any copyright disputes involving the content,
please email: Julia.Zhang@ubmsinoexpo.com to delete.